Financials data is unavailable for this security.
Cash flow in EURView more
In 2023, cash reserves at Acticor Biotech SA fell by 2.71m. Cash Flow from Financing totalled 10.36m or -- of revenues. In addition the company used 13.03m for operations while cash used for investing totalled 46.00k.
Cash flow per share | -1.48 |
---|---|
Price/Cash flow per share | -- |
Book value per share | -0.4028 |
---|---|
Tangible book value per share | -0.4028 |
More ▼
Balance sheet in EURView more
Current ratio | 0.9848 |
---|---|
Quick ratio | -- |
Total debt/total equity | -- |
---|---|
Total debt/total capital | 10.47 |
More ▼